• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COVIDIEN EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number EVX35-05-080-120
Device Problems Positioning Problem (3009); Activation Problem (4042)
Patient Problem Patient Problem/Medical Problem (2688)
Event Date 06/06/2019
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported that the physician was using an everflex entrust stent to treat a severely calcified, 80% stenotic lesion in the mid superficial femoral artery(sfa).There was no damage noted to the packaging and no issues noted when removing the device from the tray.The device was prepped per ifu without issue.No embolic protection was used.The device did not pass through a previously deployed stent and no resistance was encountered and no excessive force was applied during delivery of the device to the lesion.The thumbscrew was checked for securement prior to the procedure and the lock-pin was removed just before deployment.It was reported that the stent partially deployed in an unintended lesion.The physician deferred to surgery to remove the stent and treat the severely stenotic sfa.The patient is currently doing well.
 
Manufacturer Narrative
Additional information: the stent was removed from the patient's artery via open surgery.The patient has been discharged and is currently doing well.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Additional information: the device was successfully advanced to the target lesion prior to removing the lock tube and attempted to deploy.Deployment difficulties were encountered.The stent is reported to have wrinkled.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVERFLEX SELF-EXPANDING PERIPHERAL STENT WITH ENTRUST DELIVERY SYSTEM STANDARD
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
COVIDIEN
4600 nathan lane north
plymouth MN 55442
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key8716773
MDR Text Key148566052
Report Number2183870-2019-00341
Device Sequence Number1
Product Code NIP
Combination Product (y/n)N
Reporter Country CodeCO
PMA/PMN Number
P110023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 09/17/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/20/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date04/16/2021
Device Catalogue NumberEVX35-05-080-120
Device Lot NumberA630885
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/16/2019
Date Device Manufactured04/17/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-